
Readmission After Surgical Resection and Transplantation for Hepatocellular Carcinoma: A Retrospective Cohort Study
Author(s) -
Sidrah Khan,
Alexis P. Chidi,
Katherine Hrebinko,
Christof Kaltenmeier,
Ibrahim Nassour,
Richard S. Hoehn,
David A. Geller,
Allan Tsung,
Samer Tohme
Publication year - 2020
Publication title -
the american surgeon/american surgeon
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 93
eISSN - 1555-9823
pISSN - 0003-1348
DOI - 10.1177/0003134820973739
Subject(s) - medicine , hepatocellular carcinoma , liver transplantation , retrospective cohort study , mortality rate , cohort , hepatectomy , transplantation , cohort study , liver cancer , cancer , surgery , resection , database , computer science
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Liver resections and transplantations have increasingly become feasible options for potential cure. These complex surgeries are inherently associated with increased rates of readmission. In the meanwhile, hospital readmission rates are rapidly becoming an important quality of care metric. Therefore, it is very important to understand the effect of 30-day readmission on mortality and the factors associated with increased 30- and 90-day mortality rates.